NitroMed BiDil Launch Projected For 2005 Following Positive Study Results
This article was originally published in Pharmaceutical Approvals Monthly
Executive Summary
NitroMed is counting on a compliance benefit to get BiDil on formularies if the combination product is approved for treatment of congestive heart failure in African American patients.